➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: August 10, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Isopto Atropine, and when can generic versions of Isopto Atropine launch?

Isopto Atropine is a drug marketed by Alcon Labs Inc and is included in one NDA.

The generic ingredient in ISOPTO ATROPINE is atropine sulfate. There are twenty-three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Isopto Atropine

A generic version of ISOPTO ATROPINE was approved as atropine sulfate by AKORN on July 18th, 2014.

  Start Trial

US Patents and Regulatory Information for ISOPTO ATROPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc ISOPTO ATROPINE atropine sulfate SOLUTION/DROPS;OPHTHALMIC 208151-001 Dec 1, 2016 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.